Reply to: "Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?"

Authors

Philippa C. Matthews, The Francis Crick Institute, 1 Midland Road, London
Ponsiano Ocama, University College London, Gower St, London
Su Wang, Medical Center, Florham Park, NJ, USA
Manal El Sayed, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Anna Turkova, University College London, 90 High Holborn London
Deborah Ford, University College London, 90 High Holborn London
Judith Torimiro, esearch on Prevention and Management of HIV/AIDS USA
Homie Razavi, Center for Disease Analysis Foundation,USA
Geoffrey Dusheiko, Liver Unit, King's College Hospital, Denmark Hill, London UK
Saeed Hamid, Aga Khan UniversityFollow

Document Type

Letter to the Editor

Department

Medicine

Comments

Abstract and pagination are not provided by the author/publisher.

Publication (Name of Journal)

JHEP Reports

DOI

https://www.sciencedirect.com/science/article/pii/S2589555923002069?via%3Dihub

Recommended Citation

Matthews, P. C., Ocama, P., Wang, S., Sayed, M. E., Turkova, A., Ford, D., Torimiro, J., Razavi, H., Dusheiko, G., Hamid, S. (2023). Reply to: "Does currently recommended maternal antiviral prophylaxis against mother-to-child transmission of hepatitis B virus require enhancement?". JHEP Reports, 2(11).
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_med_med/691